Atrial flutter Market Research Resport 2032: Industry trends, Drugs, Companies and Analysis by DelveInsight | Acutus Medical, ARCA Biopharma, Adagio Medical, Abbott and Others

Atrial flutter is a kind of arrhythmia and it is a problem with the way the heart beats. Atrial flutter is called supraventricular (above the ventricles) tachycardia because it comes from the atria.
In atrial flutter, the heart's upper chambers (atria) beat too quickly. This causes the heart to beat in a fast, but usually regular, rhythm. It beats extra fast, about 250-400 beats per minute. A normal heartbeat is 60-100 beats per minute.

DelveInsight's "Atrial Flutter Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Atrial Flutter , historical and forecasted epidemiology as well as the Atrial Flutter market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

To know more details about Atrial Flutter Market Report, Click Here: https://www.delveinsight.com/report-store/atrial-flutter-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some facts of Atrial Flutter Market Report are:
• As per a study by Rahman et al. (2016), the incidence rate of flutter was 36 per 100,000 person-years and during mean follow-up of 33.0 ± 12.2 years, 112 participants (mean age 72 ± 10 years, 30% women) developed flutter.
• According to Ziccardi et al. (2020), Atrial flutter is the second most common cardiac arrhythmia after atrial fibrillation. Atrial flutter is more frequent in males than in females. Older age is associated with an increased risk of atrial fibrillation and atrial flutter.
• According to Global Health Data Exchange, nearly 8 out of 10 adults, suffering from (or diagnosed with) Atrial fibrillation or Atrial Flutter are 65 years old or older.
• According to DelveInsight's analysis, males are comparatively more affected by Atrial Flutter than females.
• As per the secondary sources more than Atrial fibrillation is the most common arrhythmia diagnosed in clinical practice. Estimates of the prevalence of AFib in the United States ranges from about 2.7 million to 6.1 million (The Centers for Disease Control and Prevention (CDC), n.d.) and 30 to 50 percent of those also have atrial flutter (Baptist health south florida, 2021).

Request for a free Sample Report: https://www.delveinsight.com/sample-request/atrial-flutter-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Atrial Flutter Market Report:
• The report covers the descriptive overview of Atrial Flutter , explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Atrial Flutter epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Atrial Flutter are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of Atrial Flutter market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Atrial Flutter market

To know more about the scope of Atrial Flutter Market Report, Click Here: https://www.delveinsight.com/report-store/atrial-flutter-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Atrial flutter is very similar to the more common condition atrial fibrillation (AFib), except for the rhythm in atrial flutter, the atrial racing tends to be regular, unlike in atrial fibrillation, where an irregular rhythm is more common. There are mainly two types of Atrial Flutter: Paroxysmal atrial flutter, which comes and go and Persistent atrial flutter, which is more or less permanent.

Atrial flutter has symptoms that are wide-ranging and can include one or more of the following conditions: Shortness of breath, anxiety, dizziness, heart palpitations, fatigue, etc. Some people have no symptoms at all with atrial flutter. Symptoms can last for hours, days, or even weeks at a time.

Some of Atrial Flutter Companies are:
• Acutus Medical
• ARCA Biopharma
• Adagio Medical
• Abbott
• And Many Others

To get detailed analysis of companies working in Atrial Flutter Market domain, Click Here: https://www.delveinsight.com/sample-request/atrial-flutter-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of Atrial Flutter Emerging therapies:
• AcQBlate Force Sensing Ablation System
• Gencaro
• And Many Others

To know more about Atrial Flutter Pipeline and Therapies, Click Here: https://www.delveinsight.com/sample-request/atrial-flutter-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents:
1. Key Insights
2. Executive Summary of Atrial Flutter
3. Competitive Intelligence Analysis for Atrial Flutter
4. Atrial Flutter Market Overview at a Glance
5. Atrial Flutter : Disease Background and Overview
6. Atrial Flutter Patient Journey
7. Atrial Flutter Epidemiology and Patient Population
8. Atrial Flutter Treatment Algorithm, Current Treatment, and Medical Practices
9. Atrial Flutter Unmet Needs
10. Key Endpoints of Atrial Flutter Treatment
11. Atrial Flutter Marketed Products
List to be continued in report
12. Emerging Atrial Flutter Therapies
List to be continued in report
13. Atrial Flutter : Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Atrial Flutter Market Outlook
16. Access and Reimbursement Overview of Atrial Flutter
17. KOL Views
18. Atrial Flutter Market Drivers
19. Atrial Flutter Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

Request for Detailed TOC: https://www.delveinsight.com/sample-request/atrial-flutter-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Contact us
Ankit Nigam
info@delveinsight.com
+91-9650213330
https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

This release was published on openPR.